[Correspondence] Fighting drug-resistant tuberculosis in eastern Europe

We read with great interest the letter from Tomasz Jagielsi and colleagues1 presenting the Fight Against TB in Central and Eastern Europe (FATE). As the authors point out, eastern Europe is a hotspot for drug-resistant tuberculosis involving countries both within and outside the EU. The correspondence rightly highlights the need for intercountry and regional collaboration; however, it does not mention the existing regional initiatives and networks including WHO's European TB Laboratory Initiative (ELI),2 the Regional Collaborating Committee on TB,3 the European Centers for Disease Prevention and Control (ECDC) networks,4 and professional societies, among others.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research